179 related articles for article (PubMed ID: 27002634)
1. Health Insurance Coverage and Hypertension Control in China: Results from the China Health and Nutrition Survey.
Liao Y; Gilmour S; Shibuya K
PLoS One; 2016; 11(3):e0152091. PubMed ID: 27002634
[TBL] [Abstract][Full Text] [Related]
2. Health insurance status and hypertension monitoring and control in the United States.
Duru OK; Vargas RB; Kermah D; Pan D; Norris KC
Am J Hypertens; 2007 Apr; 20(4):348-53. PubMed ID: 17386339
[TBL] [Abstract][Full Text] [Related]
3. Vital signs: prevalence, treatment, and control of hypertension--United States, 1999-2002 and 2005-2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Feb; 60(4):103-8. PubMed ID: 21293325
[TBL] [Abstract][Full Text] [Related]
4. Impact of local health insurance schemes on primary care management and control of hypertension: a cross-sectional study in Shenzhen, China.
Li H; Wu Z; Hui X; Hu Y
BMJ Open; 2019 Oct; 9(10):e031098. PubMed ID: 31630106
[TBL] [Abstract][Full Text] [Related]
5. Vital signs: awareness and treatment of uncontrolled hypertension among adults--United States, 2003-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Sep; 61():703-9. PubMed ID: 22951452
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with awareness, treatment and control of hypertension among 3579 hypertensive adults in China: data from the China Health and Nutrition Survey.
Wei J; Mi Y; Li Y; Xin B; Wang Y
BMC Public Health; 2021 Mar; 21(1):423. PubMed ID: 33648483
[TBL] [Abstract][Full Text] [Related]
7. Does Migration Limit the Effect of Health Insurance on Hypertension Management in China?
Fang H; Jin Y; Zhao M; Zhang H; A Rizzo J; Zhang D; Hou Z
Int J Environ Res Public Health; 2017 Oct; 14(10):. PubMed ID: 29053607
[No Abstract] [Full Text] [Related]
8. Beyond insurance coverage: usual source of care in the treatment of hypertension and hypercholesterolemia. Data from the 2003-2006 National Health and Nutrition Examination Survey.
Spatz ES; Ross JS; Desai MM; Canavan ME; Krumholz HM
Am Heart J; 2010 Jul; 160(1):115-21. PubMed ID: 20598981
[TBL] [Abstract][Full Text] [Related]
9. Spillover effects of community uninsurance on awareness, treatment, and control of hypertension among insured adults.
Escarce JJ; Edgington SE; Roan Gresenz C
Med Care; 2014 Jul; 52(7):626-33. PubMed ID: 24926710
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project).
Lu J; Lu Y; Wang X; Li X; Linderman GC; Wu C; Cheng X; Mu L; Zhang H; Liu J; Su M; Zhao H; Spatz ES; Spertus JA; Masoudi FA; Krumholz HM; Jiang L
Lancet; 2017 Dec; 390(10112):2549-2558. PubMed ID: 29102084
[TBL] [Abstract][Full Text] [Related]
11. Changes in prevalence, awareness, treatment and control of hypertension in disadvantaged French Caribbean populations, 2003 to 2014.
Carrère P; Halbert N; Lamy S; Inamo J; Atallah A; Lang T
J Hum Hypertens; 2017 Sep; 31(9):596-601. PubMed ID: 28406233
[TBL] [Abstract][Full Text] [Related]
12. [Study on effects of community-based management of hypertension patients aged ≥35 years and influencing factors in urban and rural areas of China, 2010].
Zeng XY; Zhang M; Li YC; Huang ZJ; Wang LM
Zhonghua Liu Xing Bing Xue Za Zhi; 2016 May; 37(5):612-7. PubMed ID: 27188348
[TBL] [Abstract][Full Text] [Related]
13. The impact of a value-based insurance design plus health coaching on medication adherence and medical spending.
Musich S; Wang S; Hawkins K
Popul Health Manag; 2015 Jun; 18(3):151-8. PubMed ID: 25247449
[TBL] [Abstract][Full Text] [Related]
14. Prevalence, awareness, treatment, and control of hypertension among residents in Guangdong Province, China, 2004 to 2007.
Xu B; Xu Z; Xu X; Cai Q; Xu Y
Circ Cardiovasc Qual Outcomes; 2013 Mar; 6(2):217-22. PubMed ID: 23481521
[TBL] [Abstract][Full Text] [Related]
15. Temporal trends in Prevalence, Awareness, Treatment, and Control of Hypertension from 2000 to 2010 in Chengdu, China.
Huang G; Xu JB; Liu Y; Liu ZH; Zhang YL; Wu YL; Wen RL; Zhu S; Zhang TJ
Sci Rep; 2017 Aug; 7(1):8964. PubMed ID: 28827767
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, awareness, treatment and control of hypertension in Macau: results from a cross-sectional epidemiological study in Macau, China.
Ke L; Ho J; Feng J; Mpofu E; Dibley MJ; Li Y; Feng X; Van F; Lau W; Brock KE
Am J Hypertens; 2015 Feb; 28(2):159-65. PubMed ID: 25063734
[TBL] [Abstract][Full Text] [Related]
17. Health Insurance In China: After Declining In The 1990s, Coverage Rates Rebounded To Near-Universal Levels By 2011.
Li Y; Malik V; Hu FB
Health Aff (Millwood); 2017 Aug; 36(8):1452-1460. PubMed ID: 28784738
[TBL] [Abstract][Full Text] [Related]
18. A cross-sectional study of the prevalence, awareness, treatment and control of hypertension in Shenzhen, China.
Li H; Yan X; Deng X; Yang L; Zhao S; Zou J; Luo Y; Cao S
BMJ Open; 2017 Jun; 7(6):e015206. PubMed ID: 28619776
[TBL] [Abstract][Full Text] [Related]
19. Impact of universal health insurance coverage on hypertension management: a cross-national study in the United States and England.
Dalton AR; Vamos EP; Harris MJ; Netuveli G; Wachter RM; Majeed A; Millett C
PLoS One; 2014; 9(1):e83705. PubMed ID: 24416171
[TBL] [Abstract][Full Text] [Related]
20. Effects of Health Insurance Interruption on Loss of Hypertension Control in Women With and Women Without HIV.
Edmonds A; Ludema C; Eron JJ; Cole SR; Adedimeji AA; Cohen MH; Cooper HL; Fischl M; Johnson MO; Krause DD; Merenstein D; Milam J; Wilson TE; Adimora AA
J Womens Health (Larchmt); 2017 Dec; 26(12):1292-1301. PubMed ID: 28682658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
